Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marika Heinpalu"'
Autor:
Anneli Talvik, Paola Rebora, Marika Heinpalu-Kuum, Sabrina Salerno, Eliza Miszkowska-Nagórna, Xiaoqiu Liu, Tommaso Comotti, Ewa Świerblewska, Maria Grazia Valsecchi, Fadl Elmula M. Fadl Elmula, Anne Cecilie Larstorp, Krzysztof Narkiewicz, Gianfranco Parati, Stéphane Laurent, Margus Viigimaa, for the BEtter control of blood pressure in hypertensive pAtients monitored Using the hoTman® sYstem (BEAUTY) Study Investigators
Publikováno v:
Blood Pressure, Vol 27, Iss 6, Pp 368-375 (2018)
Background: In the BEAUTY study we investigated whether utilizing non-invasive monitoring of hemodynamic parameters combined with a drug selection algorithm (integrated hemodynamic management-IHM) compared to conventional drug selection may improve h
Externí odkaz:
https://doaj.org/article/f879f1bbdfbc455ea6f2f28aeb711116
Autor:
Ewa Świerblewska, Maria Grazia Valsecchi, Eliza Miszkowska-Nagórna, Gianfranco Parati, Krzysztof Narkiewicz, Stéphane Laurent, Xiaoqiu Liu, Tommaso Comotti, Fadl Elmula M. Fadl Elmula, Anneli Talvik, Margus Viigimaa, S. Salerno, Marika Heinpalu-Kuum, Paola Rebora, Anne Cecilie K Larstorp
Publikováno v:
Blood pressure. 27(6)
In the BEAUTY study we investigated whether utilizing non-invasive monitoring of hemodynamic parameters combined with a drug selection algorithm (integrated hemodynamic management-IHM) compared to conventional drug selection may improve home BP in pa
Autor:
Eliza Miszkowska-Nagórna, Marika Heinpalu-Kuum, Sverre E. Kjeldsen, Anne Cecilie K Larstorp, Krzysztof Narkiewicz, Xiaoqiu Liu, Fadl Elmula M. Fadl Elmula, Paola Rebora, Morten Rostrup, Gianfranco Parati, Margus Viigimaa, S. Salerno, Tommaso Comotti, Stéphane Laurent, Anneli Talvik, Ewa Świerblewska, Maria Grazia Valsecchi
Publikováno v:
Journal of hypertension. 33(12)
In the BEtter control of BP in hypertensive pAtients monitored Using the HOTMAN sYstem study, we investigated whether utilizing noninvasive monitoring of hemodynamic parameters combined with a drug selection algorithm (integrated hemodynamic manageme
Autor:
Arvo Mesikepp, Jaan Eha, Lasse Lehtonen, Saila Antila, Ulle Planken, Marika Heinpalu, Pentti Põder, Juha Akkila, Imbrit Loogna
Publikováno v:
Cardiovascular Drugs and Therapy. 17:451-458
Objective: The aim was to study the pharmacodynamic interactions and safety of the co-administration of the calcium sensitizer levosimendan and the calcium antagonist felodipine in patients with coronary heart disease (CHD) and with normal ejection f
Autor:
Marika Heinpalu-Kuum, S.E. Kjeldsen, K. Narkiewicz, Margus Viigimaa, S. Laurent, E. Swierblewska, Maria Grazia Valsecchi, Xiaoqiu Liu, Gianfranco Parati, S. Salerno, Tommaso Comotti, Anneli Talvik, Paola Rebora, Eliza Miszkowska-Nagórna
Publikováno v:
Journal of Hypertension. 35:e35
Autor:
Saila Antila, Lasse Lehtonen, E P Sandell, Marika Heinpalu, Imbrit Loogna, A Mesikepp, Ulle Planken, Jaan Eha
Publikováno v:
European Journal of Clinical Pharmacology. 49:451-458
Levosimendan in a new inodilator drug that sensitizes troponin C in heart muscle cells to calcium, thus improving contractility. In previous studies, a single 2 mg intravenous dose of levosimendan increased cardiac output (CO) in healthy volunteers b
Autor:
Satu Rantanen, Ulle Planken, Lasse Lehtonen, Stig Sundberg, Jaan Eha, Imbrit Loogna, Marika Heinpalu, Pentti Põder, Saila Antila
Publikováno v:
Journal of clinical pharmacology. 44(10)
The objective of this study was to explore the pharmacodynamics and pharmacokinetics of oral levosimendan in patients with severe congestive heart failure. This was a randomized, parallel-group, double-blind, placebo-controlled trial. Oral levosimend
Pharmacodynamic Interactions of Levosimendan and Felodipine in Patients with Coronary Heart Disease.
Publikováno v:
Cardiovascular Drugs & Therapy; Sep2003, Vol. 17 Issue 5, p451-458, 8p
Autor:
Fadl Elmula FE; aSection for Cardiovascular and Renal Research, Ullevaal Hospital, Departments of Cardiology, Internal Medicine, Medical Biochemistry and Acute Medicine, and University of Oslo, Oslo Norway bDepartment of Health Sciences, University of Milan-Bicocca, Milan, Italy cNorth Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia dDepartment of Cardiology S. Luca Hospital, Istituto Auxologico Italiano, IRCCS, Italy eDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland fDepartment of Pharmacology and INSERM U970 (SL), Hôpital Européen Georges Pompidou, Paris, France *Fadl Elmula M. Fadl Elmula, Paola Rebora, Anneli Talvik, Sabrina Salerno, Xiaoqiu Liu, and Marika Heinpalu-Kuum are joint first authors. †Maria Grazia Valsecchi, Sverre E. Kjeldsen, Margus Viigimaa, Krzysztof Narkiewicz, Gianfranco Parati, and Stéphane Laurent are joint senior authors., Rebora P, Talvik A, Salerno S, Miszkowska-Nagórna E, Liu X, Heinpalu-Kuum M, Comotti T, Larstorp AC, Rostrup M, Świerblewska E, Valsecchi MG, Kjeldsen SE, Viigimaa M, Narkiewicz K, Parati G, Laurent S
Publikováno v:
Journal of hypertension [J Hypertens] 2015 Dec; Vol. 33 (12), pp. 2534-45.